158 related articles for article (PubMed ID: 31135518)
1. FDG-Avid Hürthle Cell Thyroid Adenoma.
Yu R; Auerbach MS
Clin Nucl Med; 2019 Sep; 44(9):752-753. PubMed ID: 31135518
[TBL] [Abstract][Full Text] [Related]
2. Hürthle Cell Thyroid Adenoma Showing Avid Uptake on 18F-PSMA-1007 PET/CT.
Tang K; Wang Z; Lin J; Zheng X
Clin Nucl Med; 2020 Mar; 45(3):223-224. PubMed ID: 31876816
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
Pryma DA; Schöder H; Gönen M; Robbins RJ; Larson SM; Yeung HW
J Nucl Med; 2006 Aug; 47(8):1260-6. PubMed ID: 16883003
[TBL] [Abstract][Full Text] [Related]
4. Oncocytoma: A Differential Consideration for an Incidentally Detected FDG-Avid Renal Mass on PET/CT.
Smith CJ; Wang MX; Feely M; Otto B; Grajo JR
J Radiol Case Rep; 2017 May; 11(5):27-33. PubMed ID: 29299091
[TBL] [Abstract][Full Text] [Related]
5.
Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
[No Abstract] [Full Text] [Related]
6. Fluorine-18 fluorodeoxyglucose avid thyroid incidentalomas on PET/CT scan in cancer patients: how sinister are they?
Hassan A; Riaz S; Zafar W
Nucl Med Commun; 2016 Oct; 37(10):1069-73. PubMed ID: 27571130
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
[TBL] [Abstract][Full Text] [Related]
8. Intense FDG uptake in a benign Hurthle cell adenoma.
Rohren EM
Clin Nucl Med; 2004 Oct; 29(10):664-6. PubMed ID: 15365450
[No Abstract] [Full Text] [Related]
9. Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?
Giammarile F; Hafdi Z; Bournaud C; Janier M; Houzard C; Desuzinges C; Itti R; Sassolas G; Borson-Chazot F
Eur J Endocrinol; 2003 Oct; 149(4):293-300. PubMed ID: 14514343
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET of patients with Hürthle cell carcinoma.
Lowe VJ; Mullan BP; Hay ID; McIver B; Kasperbauer JL
J Nucl Med; 2003 Sep; 44(9):1402-6. PubMed ID: 12960183
[TBL] [Abstract][Full Text] [Related]
11. Unusual Presentation of Hurthle Cell Carcinoma With TENIS Syndrome as Left Atrial Thrombus on 18F-FDG PET/CT.
Sood A; Parihar AS; Sood A; Kumar R; Prakash G; Singhal M; Gulati A; Mittal BR; Bahl A; Singh S
Clin Nucl Med; 2018 Oct; 43(10):e352-e354. PubMed ID: 30080688
[TBL] [Abstract][Full Text] [Related]
12. FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive hurthle cell tumor of the thyroid.
Wiesner W; Engel H; von Schulthess GK; Krestin GP; Bicik I
Eur Radiol; 1999; 9(5):975-8. PubMed ID: 10370003
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET characteristics of Hürthle cell and follicular adenomas.
Pathak KA; Klonisch T; Nason RW; Leslie WD
Ann Nucl Med; 2016 Aug; 30(7):506-9. PubMed ID: 27221817
[TBL] [Abstract][Full Text] [Related]
14. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas.
King DL; Stack BC; Spring PM; Walker R; Bodenner DL
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):400-4. PubMed ID: 17765765
[TBL] [Abstract][Full Text] [Related]
15. Malignant Solitary Fibrous Tumor Metastatic to Widely Invasive Hurthle Cell Thyroid Carcinoma: A Distinct Tumor-to-Tumor Metastasis.
Kolson Kokohaare E; Riva FMG; Bernstein JM; Miah AB; Thway K
Int J Surg Pathol; 2018 Sep; 26(6):521-524. PubMed ID: 29616597
[TBL] [Abstract][Full Text] [Related]
16. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
Hagenimana N; Dallaire J; Vallée É; Belzile M
J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460
[TBL] [Abstract][Full Text] [Related]
17. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
[TBL] [Abstract][Full Text] [Related]
18. Oncocytic adenomas of thyroid-mimicking benign or metastatic disease on 18F-FDG-PET scan.
Zandieh S; Pokieser W; Knoll P; Sonneck-Koenne C; Kudlacek M; Mirzaei S
Acta Radiol; 2015 Jun; 56(6):709-13. PubMed ID: 24948789
[TBL] [Abstract][Full Text] [Related]
19. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values.
Kao YH; Lim SS; Ong SC; Padhy AK
Can Assoc Radiol J; 2012 Nov; 63(4):289-93. PubMed ID: 22136969
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.
Kim H; Na KJ; Choi JH; Ahn BC; Ahn D; Sohn JH
Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1569-76. PubMed ID: 25971994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
